
Triple-agonist research peptide.
RETA is a research-grade triple-agonist peptide studied in incretin-pathway and metabolic research literature. Available in two dose sizes for varied protocol needs.
Sold for research and laboratory purposes. Research-use policy.
Research areas reference models in which this molecule appears in the published literature.
Every batch ships with a third-party certificate of analysis. Lyophilized, sealed, and stored to research-grade standards.
Freeze-dried for stability and long shelf life under proper storage.
Independent purity and identity verification — published with each batch ID.
We sequence every batch rather than relying on supplier paperwork.